Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS

BlackRock, Inc. reported a 5.40% stake in Corvus Pharmaceuticals, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Oct 17, 2025

BlackRock, Inc. reported a 5.40% stake in Corvus Pharmaceuticals, Inc., 4,015,510 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G).

Stake
5.40%
Shares
4,015,510
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.40%4,015,510

Source

View original at SEC

Related